Qisu Zhang

Risk of stroke/systemic embolism, major bleeding and associated costs in non-valvular atrial fibrillation patients who initiated apixaban, dabigatran or rivaroxaban compared with warfarin in the United States Medicare population

Alpesh Amin, Allison Keshishian, Jeffrey Trocio et al. · Current Medical Research and Opinion · 2017 · 71 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +17

National and Local Direct Medical Cost Burden of COPD in the United States From 2016 to 2019 and Projections Through 2029

David M. Mannino, Melissa Roberts, Douglas W. Mapel et al. · CHEST Journal · 2023 · 50 citations · Full text

Pharmacy, Health Policy, Pharmacoeconomics +14

Treatment Patterns, Healthcare Resource Utilization and Costs Among Schizophrenia Patients Treated with Long-Acting Injectable Versus Oral Antipsychotics

Ankit Shah, Lin Xie, Furaha Kariburyo et al. · Advances in Therapy · 2018 · 45 citations

Pharmacy, Pharmacotherapy, Psychiatry +17

Improving peripherally inserted central catheter appropriateness and reducing device-related complications: a quasiexperimental study in 52 Michigan hospitals

Vineet Chopra, Megan O’Malley, Jennifer Horowitz et al. · BMJ Quality & Safety · 2021 · 45 citations · Full text

Medicine, Nephrology, General Internal Medicine +14

Real-World Comparative Effectiveness, Safety, and Health Care Costs of Oral Anticoagulants in Nonvalvular Atrial Fibrillation Patients in the U.S. Department of Defense Population

Kiran Gupta, Jeffrey Trocio, Allison Keshishian et al. · Journal of Managed Care & Specialty Pharmacy · 2018 · 38 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17